Numbers can be astonishing!

Using our clients’ sustained preference as the outmost measure of corporate trust, we do use metrics but do not rely on numbers to measure our everyday workload and/or efficacy. Having said that, today’s numbers are astonishing: 42 running clinical trials and an additional 6 at an initiation phase; 3 products at a pre-launch phase and multiple regulatory submissions on the row. Seems like we will be busy for a while…